Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;35(1):1-11.
doi: 10.4103/0253-7184.132399.

Initiation of antiretroviral therapy

Affiliations
Review

Initiation of antiretroviral therapy

Deepika Pandhi et al. Indian J Sex Transm Dis AIDS. 2014 Jan.

Abstract

With the widespread availability of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Further, the current antiretroviral drug combinations are safer and the availability of newer monitoring assays and guidelines has vastly improved the patient management. The clinician needs to evaluate several key issues prior to institution of antiretroviral regimen including the correct stage of starting the treatment and the kind of regimen to initiate. In addition to various disease related factors, it is also critical to assess the patient's general condition including nutritional status, presence of co-morbidities and mental preparedness prior to starting the therapy. The patients need to develop an overall understanding of the treatment and its benefits and the importance of lifelong adherence to the drugs. The presence of special situations like pediatric age, older patients, pregnancy, lactation and presence of opportunistic infections also require modification of the therapy. This review briefly summarizes issues relevant to the clinician prior to the initiation of antiretroviral therapy.

Keywords: Antiretroviral therapy; HIV; children; hepatitis B and C; pregnancy; serodiscordant couples; tuberculosis; viral load.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Malteza F, Doroanab M, Branco T, Valente C. Recent advances in antiretroviral treatment and prevention in HIV-infected patients. Curr Opin HIV AIDS. 2011;6(suppl 1):S21–30. - PubMed
    1. Boyd SD. Management of HIV infection in treatment-naive patients: A review of the most current recommendations. Am J Health Syst Pharm. 2011;68:991–1001. - PMC - PubMed
    1. Chun TW, Nickle DC, Justement JS, Large D, Semerjian A, Curlin ME, et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest. 2005;115:3250–5. - PMC - PubMed
    1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents Department of Health and Human Services (last updated on February 12 2013) [Last accessed on 2013 December 10]. Available from: http://wwwaidsinfonihgov/guidelines .
    1. Nachegaa JB, Millsc EJ, Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: Current status of knowledge and research priorities. Curr Opin HIV AIDS. 2010;5:70–7. - PubMed